从不可手术到缓解:在免疫疗法-A病例报告的高级B3胸腺瘤中完全响应
Dharmaning Estu Wirastyo1, Isnin Anang Marhana1, Alfian Nur Rosyid1
1Department of Pulmonology and Respiratory Medicine, Faculty of Medicine Universitas Airlangga - Dr. Soetomo General Academic Hospital Surabaya Indonesia.
Respirology case reports
|December 11, 2025
概括
这项案例研究表明,结合手术,放射治疗和pembrolizumab免疫疗法可以有效地治疗晚期胸腺瘤,即使在不完全切除后. 这种多模式的方法导致了显著的瘤回归,并在患有侵袭性胸腺瘤的患者中改善了结果.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 胸部外科手术 胸部外科手术
背景情况:
- 胸腺瘤是一种罕见的胸腺上皮瘤.
- 晚期胸腺瘤往往呈现出不良预后,特别是在不完全切除后.
研究的目的:
- 报告一个以多模式方法治疗的晚期胸腺瘤病例.
- 为了评估 pembrolizumab 免疫疗法与手术和胸腺瘤放射疗法结合的疗效.
主要方法:
- 一名患有B3型胸腺瘤的30岁女性接受了不完全的胸腺切除术 (R2切除术).
- 他们接受了辅助放射治疗和长期的 pembrolizumab 免疫治疗.
- 连续成像,包括PET扫描,监测瘤反应.
主要成果:
- 患者在残留的代谢不活跃组织下实现了明显的瘤回归.
- 尽管初始切除不完整,但观察到有利的结果.
- 布罗利祖马布在手术后控制侵略性胸腺瘤方面表现出有效性.
结论:
- 包括免疫检查点封锁在内的多模式策略对于晚期胸腺瘤是有效的.
- 布罗利祖马布在改善残留疾病的侵袭性胸腺瘤的结果方面显示出潜力.
- 这一案例有助于在不完整的胸膜切除术后对 pembrolizumab 使用的有限证据.
更多相关视频
相关概念视频
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K